Evaluation of the improvement effects of Vitamin E on liver indexs in pationts with acute hepatitis A
Phase 3
- Conditions
- Hepatitis A acute.Acute hepatitis A
- Registration Number
- IRCT20171205037752N1
- Lead Sponsor
- Zabol University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Having Coagulopathy (Encephalopathy
intolerance po
Anti HAV positive
Exclusion Criteria
HAV positive for up to 6 months
Having a abdominal pain
Change the color of the urine
Change the stool color
jaundice
Taking any medication
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measurement of liver enzyme alanine aminotransferase. Timepoint: Measuring liver enzyme including Alanine aminotransferase before the intervention and two weeks, one, two, three, four and six months after prescribing vitamin E. Method of measurement: In the laboratory by an auto-analyzer.;Measuring the aspartate aminotransferase Liver Enzyme. Timepoint: Measuring liver enzyme including aspartate aminitransferase before the intervention and two weeks, one, two, three, four and six months after prescribing vitamin E. Method of measurement: In the laboratory by an auto-analyzer.
- Secondary Outcome Measures
Name Time Method